Azenta Analyst Ratings
Needham Reiterates Buy on Azenta, Maintains $69 Price Target
Buy Rating Justified by Azenta's Strong Q3 Performance and Growth Potential
Azenta Analyst Ratings
Evercore ISI Group Maintains In-Line on Azenta, Raises Price Target to $53
Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Azenta (AZTA)
Azenta Analyst Ratings
Needham: Maintaining the Azenta (AZTA.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $75.00.
Azenta Analyst Ratings
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Azenta Analyst Ratings
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Azenta Analyst Ratings
Azenta Analyst Ratings
Buy Rating Affirmed: Azenta's Strong Financial Outlook and Strategic Growth Trajectory
Azenta Analyst Ratings
Azenta Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Azenta (AZTA), Neurocrine (NBIX) and McKesson (MCK)
Azenta Analyst Ratings